Literature DB >> 8687402

Autoprocessing: an essential step for the activation of HIV-1 protease.

M Wan1, M Takagi, B N Loh, X Z Xu, T Imanaka.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) expresses its structural and functional proteins within Gag-Pol precursor polyproteins. Specific proteolytic processing of the precursors by the viral protease is critical for the maturation and infectivity of viral particles. To observe the influence of autoprocessing on the activation of recombinant HIV-1 protease, we constructed different HIV-1 protease forms, with or without the Phe-Pro bond directly upstream of the protease domain, and expressed them in Escherichia coli systems. We found that the presence of a short upstream sequence of the protease domain, which could generate the original N-terminus of the protease by autoproteolysis of the Phe-Pro bond, resulted in processing of active protease, whereas for a wild-type protease extended only with the initiator methionine, the proteolytic activity was not recovered. Our results suggested that autoprocessing of the direct upstream sequence of the protease domain is an essential step for the activation of recombinant HIV-1 protease in the E. coli expression system. Expression of HIV-1 protease as fusion proteins revealed that the existence of a fusion portion increased the accumulation of expressed protease by affecting its homotypic dimer formation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8687402      PMCID: PMC1217386          DOI: 10.1042/bj3160569

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  35 in total

1.  Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease.

Authors:  A Wlodawer; M Miller; M Jaskólski; B K Sathyanarayana; E Baldwin; I T Weber; L M Selk; L Clawson; J Schneider; S B Kent
Journal:  Science       Date:  1989-08-11       Impact factor: 47.728

2.  Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1.

Authors:  H G Göttlinger; J G Sodroski; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

3.  Substitution mutations of the highly conserved arginine 87 of HIV-1 protease result in loss of proteolytic activity.

Authors:  J M Louis; C A Smith; E M Wondrak; P T Mora; S Oroszlan
Journal:  Biochem Biophys Res Commun       Date:  1989-10-16       Impact factor: 3.575

4.  Processing of in vitro-synthesized gag precursor proteins of human immunodeficiency virus (HIV) type 1 by HIV proteinase generated in Escherichia coli.

Authors:  H G Kräusslich; H Schneider; G Zybarth; C A Carter; E Wimmer
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

5.  In vivo and in vitro autoprocessing of human immunodeficiency virus protease expressed in Escherichia coli.

Authors:  C Z Giam; I Boros
Journal:  J Biol Chem       Date:  1988-10-15       Impact factor: 5.157

6.  An 11-kDa form of human immunodeficiency virus protease expressed in Escherichia coli is sufficient for enzymatic activity.

Authors:  M C Graves; J J Lim; E P Heimer; R A Kramer
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

7.  Processing protease and reverse transcriptase from human immunodeficiency virus type I polyprotein in Escherichia coli.

Authors:  J Mous; E P Heimer; S F Le Grice
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

8.  Human immunodeficiency virus protease. Bacterial expression and characterization of the purified aspartic protease.

Authors:  P L Darke; C T Leu; L J Davis; J C Heimbach; R E Diehl; W S Hill; R A Dixon; I S Sigal
Journal:  J Biol Chem       Date:  1989-02-05       Impact factor: 5.157

9.  Role of human immunodeficiency virus type 1-specific protease in core protein maturation and viral infectivity.

Authors:  C Peng; B K Ho; T W Chang; N T Chang
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

10.  Partial purification and substrate analysis of bacterially expressed HIV protease by means of monoclonal antibody.

Authors:  J Hansen; S Billich; T Schulze; S Sukrow; K Moelling
Journal:  EMBO J       Date:  1988-06       Impact factor: 11.598

View more
  5 in total

1.  The dimer interfaces of protease and extra-protease domains influence the activation of protease and the specificity of GagPol cleavage.

Authors:  Steven C Pettit; Sergei Gulnik; Lori Everitt; Andrew H Kaplan
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

2.  Understanding HIV-1 protease autoprocessing for novel therapeutic development.

Authors:  Liangqun Huang; Chaoping Chen
Journal:  Future Med Chem       Date:  2013-07       Impact factor: 3.808

3.  Initial cleavage of the human immunodeficiency virus type 1 GagPol precursor by its activated protease occurs by an intramolecular mechanism.

Authors:  Steven C Pettit; Lorraine E Everitt; Sumana Choudhury; Ben M Dunn; Andrew H Kaplan
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

4.  RC1339/APRc from Rickettsia conorii is a novel aspartic protease with properties of retropepsin-like enzymes.

Authors:  Rui Cruz; Pitter Huesgen; Sean P Riley; Alexander Wlodawer; Carlos Faro; Christopher M Overall; Juan J Martinez; Isaura Simões
Journal:  PLoS Pathog       Date:  2014-08-21       Impact factor: 6.823

5.  Construction of a molecular clone of ovine enzootic nasal tumor virus.

Authors:  Scott R Walsh; María Carla Rosales Gerpe; Sarah K Wootton
Journal:  Virol J       Date:  2016-12-30       Impact factor: 4.099

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.